Neurocognitive Disorders Flashcards
What is the core feature in Neurocognitive Disorders?
Acquired Dysfunction in a cognitive domain that occurs after “early life”
What are the Domains of Cognition?
- Memory
- Language
- Executive function
- Visuospatial functioning
- Attention
Diagnostic Criteria for Delirium (AKA: acute confusional state, acute brain syndrome)
- Disturbance in awareness and attention
- Additional disturbance in a cognitive domain
- Sudden onset-symptoms typically fluctuate during the day
- Evidence for a direct physiological cause (ETOH withdrawal etc)
Risk Factors for Delirium
(modifiable, non modifiable)
Non-modifiable: poor health, old age, male
Modifiable: immobilization, sleep disturbance, ICU setting
Course of Delirium
- Symptoms persist until causal factors are treated
- Resolution typically within 3-7 days
- Amnesia common during delirium
- Poor prognostic sign for long-term survival in long ICU stays
Treatment for Delirium
- Treat underlying condition
- Antipsychotics-for associated symptomology
- Environmental Support measures (bed rails, lights)
Benzos are a risk factor for delirium-USED TO TX ETOH WITHDRAWAL
Dementia Diagnostic Criteria
Multiple and severe cognitive impairment without impaired consciousness
* progressive and irreversible
* more common in elderly (>65)
If no impairment in ADLs-Mild Cognitive Impairment
Alzheimer’s Dementia (AD)
- Significant memory impairment plus 1 other cognitive domain
- Gradual onset and steadily progressive decline
- Must exclude other symptoms (stroke)
3 Types of Alzheimers Dementia
- Early stage: memory deficits and word finding problems (anomia)-rapid forgetting
- Middle Stage: Agnosias (inability to identify/comprehend meaning of stimuli-mood changes, personality changes, psychosis
- End stage: Global cognitive impairment, motor deficits, and death from opportunistic infections
Middle Stage: ADL’s compromised. End Stage: round the clock asstance
Neuropathology of Alzheimers Disease
- Hippocampus atrophy
- Enlarged ventricles
- Cortical Atrophy
Neurochemistry of Alzheimers Disease
- Acetylcholine decreases (important for memory function
- Drugs try to increase ACH and decrease glutamate
Alzheimers Disease Neuropathology
Neurofunctional/Histopathological
- Reduced metabolism in posterior parts of brain (parietal and temporal lobes)
- Beta-Amyloid plaques and neurofibrillary tangles
- Detection of amyloid in brain by: CSF, PET imaging
Definitive Dx can only be made post-mortem by brain tissue sample
Genetics of Alzheimers Disease
- Early-Onset ( less than 65 years) strong genetic component
3 genes (chromosome 1,14, 21)
* If 1 copy of the gene is inherited-the person WILL develop early onset AD - Late-Onset: Chromosome 19 -1 or 2 copies increase chance of developing
APOLIPOPROTEIN E (APOE) late-onset
Drugs that treat Alzheimers Disease
1.Increase Acetylcholine (cholinesterase inhibitors): Donepezil, Galantamine, Rivastigmine
2. Decrease glutamate (NMDA-receptor blockers): Memantine
3. Decrease amyloids (prevent plaque formation) Aducanumab
NO NEUROLEPTICS (ANTIPSYCHOTICS) INCREASED MORTALITY
Vascular Diagnosis
Alzheimer differential
Symptoms of vascular disease (HTN, elevated BMI)
Stepwise progression of dementia symptoms